Home
Posts
Amgen to Offer Repatha Directly to Patients for Less Than Other Countries Are Paying

Amgen to Offer Repatha Directly to Patients for Less Than Other Countries Are Paying

And it’s a big day for IRA lawsuits, with Novo’s suit rejected by an appeals court even as a second court prepares to hear PhRMA make its case

Oct 7, 2025

Subscribe to Cost Curve Apex to read the rest.

Upgrade to Apex to get access to this post and other subscriber-only content.

No posts found